Natrijev Klorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natrijev Klorid Fresenius Kabi, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and sodium chloride balance in patients with fluid loss, electrolyte disturbances, or low blood sodium.

GNH USA supplies Natrijev Klorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology units worldwide. The company ensures quality compliance with EU standards and provides reliable logistics for global distribution.

Natrijev Klorid is an intravenous electrolyte used to manage conditions involving fluid loss and sodium imbalance.

Fluid replacement: restores intravascular volume in patients with dehydration, blood loss, or burns. Electrolyte replenishment: corrects sodium deficits in hyponatremic states. Hypovolemia: supports circulatory volume in shock or severe fluid depletion. Hyponatremia: raises serum sodium concentration to safe levels in acute or chronic cases.

Administration of sodium chloride injection may be associated with the following adverse reactions.

Common Side Effects: - Injection site irritation: pain, redness, or swelling at the infusion site. - Mild hypernatremia: transient elevation of serum sodium in patients receiving large volumes. - Fluid overload: signs of edema or increased blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Severe hypernatremia: rapid rise in serum sodium leading to neurological symptoms. - Anaphylactic reaction: rare hypersensitivity causing respiratory distress or shock. - Electrolyte imbalance: severe shifts in potassium or calcium levels secondary to rapid infusion.

Before using Natrijev Klorid, consider the following precautions to ensure safe administration.

- Assess fluid status: evaluate patient’s volume status and electrolyte levels prior to infusion. - Monitor serum electrolytes: check sodium and chloride concentrations regularly during therapy. - Adjust infusion rate: tailor the administration speed to the patient’s clinical condition and cardiac function. - Use aseptic technique: ensure sterile handling of the solution and infusion set. - Contraindications: avoid use in patients with documented hypersensitivity to sodium chloride. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride may interact with certain medications, influencing fluid and electrolyte balance.

Major Interactions (Avoid): - Hypertonic solutions: co‑administration with other hypertonic IV fluids can cause severe hypernatremia. - High‑dose potassium chloride: simultaneous infusion may precipitate dangerous electrolyte disturbances. - Loop diuretics in high doses: can lead to rapid shifts in sodium and fluid status.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance risk of hyperkalemia when combined with sodium chloride therapy. - NSAIDs: can affect renal handling of sodium, requiring closer monitoring of fluid balance. - Corticosteroids: may potentiate fluid retention, necessitating observation of blood pressure.